SciMetrika is a fast-growing, privately held business with a singular focus on advancing human health. Founded in 2001, the company serves public and private sector clients seeking to understand and influence population health outcomes. SciMetrika's multidisciplinary teams, mature business processes and unwavering focus on advancing human health allow SciMetrika to offer wide-ranging services that are unmatched by other businesses in this market space.
Expert Collections containing SciMetrika
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
SciMetrika is included in 2 Expert Collections, including Value-Based Care & Population Health.
Value-Based Care & Population Health
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest SciMetrika News
Oct 2, 2013
Tobacco Product Policy Research Contract To SciMetrika Population Health Consulting Firm's Findings May Influence Regulation Of Popular Tobacco Products Like Electronic Cigarettes DURHAM, N.C., Sept. 30, 2013 – SciMetrika, LLC, a population health consulting firm, has announced that the company has been awarded a $40 million, Indefinite Delivery/Indefinite Quantity (IDIQ) single-award contract by the Federal Drug Administration (FDA) to research and analyze the feasibility of various policy options for regulating certain tobacco products. SciMetrika’s research findings could influence a range of policies, including regulations related to electronic cigarettes or flavored tobacco products. Under the terms of the contract, SciMetrika will be responsible for assembling a team of multidisciplinary public health professionals who will collect and synthesize evidence concerning tobacco products and inform the development of regulatory policy options to the FDA’s Center for Tobacco Products (CTP). The contract will span five years. Project work began in September 2013. In 2009, Congress passed the Family Smoking Prevention and Tobacco Control Act, which gave the FDA authority to regulate tobacco products. CTP’s responsibilities for implementing the Family Smoking Prevention and Tobacco Control Act include: - Setting performance standards - Reviewing premarket applications for new and modified-risk tobacco products - Proposing and implementing new cigarette pack warning labels - Eliminating flavor additives (except menthol) in cigarettes - Investigating and ruling on the possible elimination of menthol flavoring in cigarettes - Proposing a plan to regulate other tobacco products, such as cigars and smokeless tobacco - Establishing and enforcing advertising and promotion restrictions SciMetrika will consult with other companies as well as subject matter experts from schools of public health at leading universities to offer augmented expertise and services in specialized areas. The organizations include Gesellschaft für Konsumforschung (Society for Consumer Research), Abt SRBI, the University of North Carolina at Greensboro and JBS International, Inc. QUOTES: “We are excited to work with the FDA’s Center for Tobacco Products to assist in the development of regulatory policy options,” said Dr. Michael Samuhel, SciMetrika director of population health sciences. “We are looking forward to sharing our findings with the FDA and CTP and to doing our part in eliminating tobacco-related disease and mortality.” “We are excited for the opportunity to provide research and present evidence to the FDA Center for Tobacco Products on this project,” said SciMetrika CEO Dr. Jean Orelien. “SciMetrika’s staff understands the special attention required for an initiative as important as the regulation of tobacco products. We look forward to serving the FDA using our deep knowledge of population health.” ABOUT SCIMETRIKA: SciMetrika, LLC is a fast- growing, privately held business with a singular focus on advancing human health. Founded in 2001, the company serves public and private sector clients seeking to understand and influence population health outcomes. SciMetrika's multidisciplinary teams, mature business processes and unwavering focus on advancing human health allow SciMetrika to offer wide-ranging services that are unmatched by other businesses in this market space. For more information, please visit http://www.scimetrika.com or call (919) 354-5200.
SciMetrika Frequently Asked Questions (FAQ)
Where is SciMetrika's headquarters?
SciMetrika's headquarters is located at 100 Capitola Drive, Durham.
What is SciMetrika's latest funding round?
SciMetrika's latest funding round is Grant.
How much did SciMetrika raise?
SciMetrika raised a total of $40M.
Who are the investors of SciMetrika?
Investors of SciMetrika include U.S. Food and Drug Administration.